Dr. Daniel Yoshio Sugai , MD
Dermatology • Bellevue, WA
1200 112th Ave Ne Ste C187
Bellevue, WA 980043749
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 13, 2012; this date does not establish years in practice.
-
Published CMS data list 4,671 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 17003 — Destruction of precancer skin growth, 2-14 growths: 2,411 service units.
- 17000 — Destruction of precancer skin growth, 1 growth: 583 service units.
- 99214 — Established patient outpatient office visit: 378 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 16 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 855 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole — 233 prescription fills, including refills.
- Mupirocin — 98 prescription fills, including refills.
- Triamcinolone Acetonide — 67 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 20 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 85% of clinicians listed under Dermatology in Bellevue, WA (2024, 17 clinicians with data). Median for this group: 799. Middle half: 399 to 3,001.
More Medicare Part B services than 85% of clinicians listed under Dermatology in Washington (2024, 244 clinicians with data). Median for this group: 1,749. Middle half: 802 to 3,541.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 4,510 in 2020 to 4,671 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1200 112th Ave Ne Ste C187
Bellevue, WA 980043749
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
NPPES lists 2 distinct additional practice-address records in Boston, MA; Renton, WA. See the list
Source: CMS NPPES NPI Registry, practice location records; release date unavailable.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File
University Of Hawaii John A. Burns School Of Medicine
2012
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
433 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $265,939 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $193,699 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
951 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$128,306 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $53,538.31 across 186 records.
By nature of payment (3 largest of 4)
- Consulting Fee: $45,000.00 across 2 records.
- Travel and Lodging: $4,817.90 across 3 records.
- Food and Beverage: $3,621.41 across 180 records.
Reporting-company totals (3 largest of 19)
- Incyte Corporation: $45,139.96 across 10 records.
- Galderma Laboratories, L.P.: $5,070.33 across 16 records.
- Janssen Pharmaceuticals, Inc: $533.74 across 27 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
14 years (graduated 2012)
CMS Doctors and Clinicians data list 2012 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File.
NPI first issued
2012
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Enrolled in Medicare (PECOS)
Dr. Sugai has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Sugai as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Bellevue and Washington
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 85% of clinicians listed under Dermatology in Bellevue, WA (2024, 17 clinicians with data). Median for this group: 799. Middle half: 399 to 3,001.
More Medicare Part B services than 85% of clinicians listed under Dermatology in Washington (2024, 244 clinicians with data). Median for this group: 1,749. Middle half: 802 to 3,541.
Medicare-allowed amount
A higher Medicare-allowed amount than 80% of clinicians listed under Dermatology in Bellevue, WA (2024, 17 clinicians with data). Median for this group: $64,310. Middle half: $22,705 to $221,800.
A higher Medicare-allowed amount than 80% of clinicians listed under Dermatology in Washington (2024, 244 clinicians with data). Median for this group: $118,488. Middle half: $57,562 to $224,878.
Paid by Medicare
A higher Medicare payment amount than 80% of clinicians listed under Dermatology in Bellevue, WA (2024, 17 clinicians with data). Median for this group: $43,647. Middle half: $16,165 to $152,453.
A higher Medicare payment amount than 80% of clinicians listed under Dermatology in Washington (2024, 244 clinicians with data). Median for this group: $81,409. Middle half: $39,184 to $154,214.
Medicare Part D prescriptions
More Part D prescriptions than 80% of clinicians listed under Dermatology in Bellevue, WA (2024, 19 clinicians with data). Median for this group: 404. Middle half: 158 to 610.
More Part D prescriptions than 70% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: 484. Middle half: 214 to 862.
Part D drug cost
A higher Part D drug cost than 65% of clinicians listed under Dermatology in Bellevue, WA (2024, 19 clinicians with data). Median for this group: $42,823. Middle half: $3,364 to $138,037.
A higher Part D drug cost than 60% of clinicians listed under Dermatology in Washington (2024, 278 clinicians with data). Median for this group: $65,882. Middle half: $7,804 to $224,271.
31 active clinicians are listed under Dermatology with a practice address in Bellevue, WA (384 in Washington).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Bellevue
6.5% of these 31 clinicians have the CMS telehealth indicator.
58.1% of these 31 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services varied from year to year: 4,510 in 2020 and 4,671 in 2024.
- 2020: 4,510
- 2021: 8,755
- 2022: 6,416
- 2023: 6,374
- 2024: 4,671
-
Medicare-allowed amount
Medicare-allowed amount varied from year to year: $261,318 in 2020 and $265,939 in 2024.
- 2020: $261,318
- 2021: $346,565
- 2022: $377,614
- 2023: $372,528
- 2024: $265,939
-
Paid by Medicare
Paid by Medicare varied from year to year: $193,137 in 2020 and $193,699 in 2024.
- 2020: $193,137
- 2021: $258,074
- 2022: $277,139
- 2023: $271,453
- 2024: $193,699
-
Medicare Part D prescriptions
Medicare Part D prescriptions increased 29% from 665 in 2020 to 855 in 2024.
- 2020: 665
- 2021: 838
- 2022: 764
- 2023: 898
- 2024: 855
-
30-day fills
30-day fills increased 30% from 730 in 2020 to 951 in 2024.
- 2020: 730
- 2021: 925
- 2022: 856
- 2023: 1,013
- 2024: 951
-
Part D drug cost
Part D drug cost increased 369% from $27,378 in 2020 to $128,306 in 2024.
- 2020: $27,378
- 2021: $31,316
- 2022: $24,485
- 2023: $131,132
- 2024: $128,306
-
Industry payments (Open Payments)
Industry payments (Open Payments) increased 1797% from $2,822.02 in 2021 to $53,538.31 in 2025.
- 2021: $2,822.02
- 2022: $19,597.80
- 2023: $29,491.07
- 2024: $191,886.42
- 2025: $53,538.31
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 186 records totaling $53,538.31.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| Incyte Corporation |
Consulting Fee
Cash or cash equivalent
|
— | General | $22,500.00 |
| Incyte Corporation |
Consulting Fee
Cash or cash equivalent
|
— | General | $22,500.00 |
| Galderma Laboratories, L.P. |
Travel and Lodging
In-kind items and services
|
— | General | $3,427.97 |
| Galderma Laboratories, L.P. |
Travel and Lodging
In-kind items and services
|
— | General | $702.58 |
| Galderma Laboratories, L.P. |
Travel and Lodging
In-kind items and services
|
— | General | $687.35 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
— | General | $141.10 |
| Janssen Pharmaceuticals, Inc |
Education
In-kind items and services
|
TREMFYA | General | $99.00 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $49.47 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $46.30 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $46.01 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $45.96 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $42.51 |
| LEO Pharma Inc. |
Food and Beverage
In-kind items and services
|
ANZUPGO | General | $41.73 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $41.49 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $40.26 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $38.87 |
| Sanofi and Genzyme US Companies |
Food and Beverage
In-kind items and services
|
DUPIXENT | General | $38.66 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $37.35 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $37.10 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $34.70 |
| Organon LLC |
Food and Beverage
In-kind items and services
|
HADLIMA | General | $33.51 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $33.42 |
| Regeneron Pharmaceuticals, Inc. |
Food and Beverage
In-kind items and services
|
LIBTAYO | General | $33.32 |
| SUN PHARMACEUTICAL INDUSTRIES INC. |
Food and Beverage
In-kind items and services
|
ILUMYA | General | $32.98 |
| UCB, Inc. |
Food and Beverage
In-kind items and services
|
Bimzelx | General | $32.35 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
2,411 | 324 | $20.00 | $7.69 |
|
17000
Destruction of precancer skin growth, 1 growth
|
583 | 361 | $220.00 | $57.38 |
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
378 | 221 | $358.00 | $140.37 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
361 | 246 | $246.00 | $99.20 |
|
17110
Destruction of skin growth, 1-14 growths
|
293 | 181 | $377.00 | $129.04 |
|
11102
Biopsy of related skin growth, first growth
|
244 | 174 | $338.00 | $91.73 |
|
17004
Destruction of precancer skin growth, 15 or more growths
|
86 | 59 | $513.00 | $191.40 |
|
11103
Biopsy of related skin growth, each additional growth
|
70 | 42 | $182.00 | $57.45 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
66 | 57 | $152.00 | $63.11 |
|
13101
Complicated repair of wound of trunk, 2.6-7.5 cm
|
33 | 23 | $1355.00 | $448.91 |
|
11602
Removal of cancer skin growth of body, arms, or legs, 1.1-2.0 cm
|
32 | 27 | $839.00 | $138.61 |
|
13121
Complicated repair of wound of scalp, arms, or legs, 2.6-7.5 cm
|
29 | 24 | $1455.00 | $479.43 |
|
11603
Removal of cancer skin growth of body, arms, or legs, 2.1-3.0 cm
|
25 | 18 | $954.00 | $156.80 |
|
J3301
Injection, triamcinolone acetonide, not otherwise specified, 10 mg
|
22 | 11 | $15.82 | $0.94 |
|
11900
Injection into skin growth, 1-7 growths
|
20 | 12 | $184.00 | $46.29 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
18 | 18 | $357.00 | $123.20 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 233 | 7,926 | $2,889.21 | 124 |
| Mupirocin | Mupirocin | 98 | 2,225 | $744.97 | 76 |
| Triamcinolone Acetonide | Triamcinolone Acetonide | 67 | 1,916 | $447.78 | 56 |
| Clobetasol Propionate | Clobetasol Propionate | 67 | 2,215 | $3,486.46 | 40 |
| Betamethasone Dipropionate | Betamethasone Dipropionate | 48 | 1,321 | $2,065.64 | 37 |
| Metronidazole | Metronidazole | 36 | 1,083 | $2,108.61 | 18 |
| Fluocinonide | Fluocinonide | 36 | 1,185 | $1,171.69 | 23 |
| Ciclopirox | Ciclopirox | 32 | 1,043 | $1,197.18 | 22 |
| Doxycycline Hyclate | Doxycycline Hyclate | 31 | 1,508 | $885.34 | 17 |
| Econazole Nitrate | Econazole Nitrate | 30 | 887 | $866.33 | 22 |
| Hydrocortisone | Hydrocortisone | 27 | 733 | $141.90 | 19 |
| Minocycline Hcl | Minocycline Hcl | 26 | 502 | $335.47 | 13 |
| Fluorouracil | Fluorouracil | 24 | 661 | $1,523.35 | 23 |
| Clindamycin Phosphate | Clindamycin Phosphate | 22 | 660 | $1,082.22 | 13 |
| Valacyclovir | Valacyclovir Hcl | 15 | 404 | $118.01 | — |
| Tretinoin | Tretinoin | 15 | 480 | $1,390.28 | 11 |
| Nystatin | Nystatin | 14 | 333 | $146.87 | — |
| Otezla | Apremilast | 12 | 360 | $57,823.48 | — |
| Plaquenil | Hydroxychloroquine Sulfate | 11 | 330 | $8,331.09 | — |
| Adbry | Tralokinumab-Ldrm | 11 | 308 | $41,550.52 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - DERMATOLOGY
I20160521000029
WA
9638306822
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Secondary Practice Locations
330 Brookline Ave
Boston, MA 022155400
Phone: 6176677000
1412 Sw 43rd St Ste 205
Renton, WA 980574803
Phone: 4252640660
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Dermatology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Internal Medicine (license number reported to NPPES: MA 252206)
Registered at 1200 112TH AVE NE STE C187, BELLEVUE, WA 980043749 (Tel: (425) 457-7900)
Dermatology (license number reported to NPPES: WA MD.60631007)
NPI status registered as active in NPPES database
Registered at 1412 SW 43RD ST STE 205, RENTON, WA 980574803 (Tel: 4252640660)
Registered at 1200 112TH AVE NE, STE C187, BELLEVUE, WA 980043749 (Tel: (425) 457-7900)
Recorded as DANIEL SUGAI, M.D.
Internal Medicine (license number reported to NPPES: MA 252206)
NPI status registered as active in NPPES database
Registered at 330 BROOKLINE AVE, BOSTON, MA 022155400 (Tel: 6176677000)
Registered at 1200 112TH AVE NE, STE C187, BELLEVUE, WA 980043749 (Tel: 4254577900)
Recorded as DANIEL SUGAI, M.D.
Single Specialty (license number reported to NPPES: WA MD.MD.60631007)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Bellevue
- Dr. Jacob Mojeski, MD
- Dr. Jing Liu, MD
- Dr. Natalie Kash, MD
- Sarah Stano
- Dr. Lawrence Gogenola, MD
- Dr. Christopher Henderson, MD
Mailing Address
1200 112th Ave Ne, Ste C187
Bellevue, WA 980043749
Phone: 4254577900